Town Square

Post a New Topic

Remdesivir treatment shows 62% reduction in COVID-19 deaths

Original post made on Jul 14, 2020

The experimental antiviral drug remdesivir reduced the mortality rate in severely ill COVID-19 patients by 62%, Foster City-based manufacturer Gilead Sciences announced Friday.

Read the full story here Web Link posted Tuesday, July 14, 2020, 4:58 PM

Comments (2)

Posted by resident
a resident of Community Center
on Jul 14, 2020 at 5:26 pm

The remdesivir effectiveness news is great, but the USA has so many serious cases of COVID now that hospitals are running out of the drug. Deciding who gets the available supply is a big ethics problem.

Posted by JT
a resident of Another Palo Alto neighborhood
on Jul 15, 2020 at 11:15 am

It would be awesome if you also reported on the great outcomes of HCQ. It has helped many patients as well, instead of reporting on "the anti-malarial drug touted by President Donald Trump" There are many articles out there, you just have to research but that should come easy in your journalism profession.

Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.


Post a comment

Sorry, but further commenting on this topic has been closed.

Stay informed.

Get the day's top headlines from Palo Alto Online sent to your inbox.

Why does it take Palo Alto so long to get things done?
By Diana Diamond | 16 comments | 2,758 views

By Chandrama Anderson | 1 comment | 2,266 views

Town & Country welcomes SF's Wildseed, a 100% plant-based eatery
By The Peninsula Foodist | 0 comments | 2,172 views